First patient undergoes Luxturna gene therapy on NHS
Jake Ternet, patient at Moorfields Eye Hospital was the first in the UK to receive the treatment.
18th February 2020
-
A fellowship for health?
The new NHS – customer or strategic partner for pharma in 2020 and beyond?
-
Game changers
Jenny Ousbey on the ‘hot’ new MPs to watch in health
-
Driving change
Recognising the role of communications in building a sustainable business
News
View all
MS Society launches ‘first-of-its-kind’ fatigue course
The Society hopes that the new online function will relieve pressure on healthcare professionals, and could result in significant cost savings for the NHS as demand for the face-to-face programme lessens.
18th February 2020
New technique developed to ‘listen in’ on cancer cells
Understanding how cells communicate could reveal how tumours are able to evade the immune system and become resistant to treatments.
18th February 2020
Scientists create ‘most detailed’ breast cancer map ever
To develop the maps, the team looked within 483 different tumour samples for the presence of 37 key proteins.
18th February 2020
Beovu bags EU approval in wet AMD
The drug is the first EC-approved anti-VEGF treatment to demonstrate superior resolution of retinal fluid, compared to Bayer's Eylea.
18th February 2020
Top trending
-
NICE refuses Keytruda, Inlyta cancer combo
-
Keytruda hits endpoints in triple-negative breast cancer
-
Novartis unveils new London HQ
-
Gilead joins GSK, J&J in offering coronavirus vaccine options
-
Another mid-late stage Alzheimer’s flop, this time for Lilly
-
More prescription ranitidine recalled from shelves
Web Exclusives
View all
How tech advancements are impacting cancer research
Giving cancer research the best chance of success
Treating a label like a machine Is transformational
The pharmaceutical industry has a head-start on heavyweight compliance and legacy product transparency requirements but do medical device manufacturers bring new advantage from an engineering mindset?
The fork in the road
Gilead's Hilary Hutton-Squire on industry, innovation, and the NICE Methods Review
The dangers of reduced market choice in life sciences
Industry consolidation continues apace, harming competition and reducing choice. Alan White warns that customers now need to be more discerning when assessing suppliers’ relative value.
Magazine
View more from the latest edition
A fellowship for health?
The new NHS – customer or strategic partner for pharma in 2020 and beyond?
Game changers
Jenny Ousbey on the ‘hot’ new MPs to watch in health
After shock?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of the Tories’ historic win on the NHS and pharma in 2020 and beyond
A glowing future
It’s the start of a glorious new decade for pharma. As the advances in medtech, gadgets and innovation jump into hyperspace, a completely rebooted pharmaverse awaits us. The new era offers the chance to inspire and define, while navigating it will represent the trip of a lifetime
Driving change
Recognising the role of communications in building a sustainable business
Patient Files: Ataxia
Alan Thomas talks about his experiences with this rare disease
Powered by partnerships
Dr Arash Tahbaz says partnerships across industry, charities, academia and the NHS will be the driving force of the next wave of health innovation
Money talks
Paul Ranson looks at pharma pricing and reimbursement in the EU
Thought Leadership
View all
The Trust Deficit - blockchain toward transparency
Blockchain is quickly moving from interesting pilots to clear use cases as a source of trust
Deep impact
The NHS Long Term Plan and what the industry response should be
The Value Exchange
Simon Grime, of Wilmington Healthcare, explains the principles of exchanging value with customers to gain trust and consent
Continuity in a time of uncertainty
Tony Cordrey, vice president of European Strategic Operations Accord Healthcare, stresses the importance of ensuring consistency and continuity in medicines supply
Webinars
View allDesigning Pharma organisations for success
Across all industries, people are changing the ways they engage with products, services, and brands. View more...
Wednesday, 28 September 2016 - 11:00 am
George Underwood
FREE - Listen again now - | VIEW NOW
